Macasling, Jm E.

HRN: 14-27-95  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
08/31/2022
09/07/2022
PO
5ml
BID
Pneumonia
Waiting Final Action 
08/31/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
08/31/2022
09/07/2022
PO
5ml
BID
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: